Avanos Medical (AVNS) Income from Continuing Operations (2013 - 2026)

Avanos Medical has disclosed Income from Continuing Operations across 14 years of filings, most recently posting 5100000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 5100000.0, down 22.73% year-over-year; the trailing twelve-month figure through Mar 2026 was 74400000.0 (up 80.43% YoY), and the FY2025 annual result was 72900000.0, up 81.13% from the prior year.
• Income from Continuing Operations came in at 5100000.0 for Q1 2026 at Avanos Medical, up from 1300000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 11000000.0 in Q3 2022 to a low of 397000000.0 in Q4 2024.
• The 5-year median for Income from Continuing Operations is 4300000.0 (2024), against an average of 25476470.59.
• Across the five-year window, Income from Continuing Operations sank 3709.09% in 2024 and surged 1220.0% in 2025, its largest moves.
• Avanos Medical's Income from Continuing Operations stood at 9700000.0 in 2022, then gained by 13.4% to 11000000.0 in 2023, then tumbled by 3709.09% to 397000000.0 in 2024, then soared by 99.67% to 1300000.0 in 2025, then surged by 492.31% to 5100000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 5100000.0 (Q1 2026), 1300000.0 (Q4 2025), and 1400000.0 (Q3 2025), per Business Quant data.